NMTC Stock Analysis: Buy, Sell, or Hold?
NMTC - NeuroOne Medical Technologies Corporation Common Stock
$1.56
-0.02 (-1.27%)
▼
5d:
-6.02%
30d:
+2.63%
90d:
-51.85%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When NMTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NMTC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NMTC shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NMTC is currently trading at $1.56, which is considered oversold relative to its 30-day fair value range of $1.57 to $1.99.
Technical Outlook: Technically, NMTC is in a strong downtrend. The price is currently testing key support at $1.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NMTC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.27 (+365.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NMTC is in a strong downtrend. The price is currently testing key support at $1.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NMTC scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.27 (+365.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.57 -
$1.99
Company Quality Score
40/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: Trading 365.8% below Wall St target ($7.27)
- WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.57 -
$1.99
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.55
Resistance Level
$1.96
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.46
Wall Street Target
$7.27
(+365.8%)
Revenue Growth (YoY)
16.3%
Profit Margin
-59.7%
Share & Embed Analysis
Last updated: September 12, 2026 3:33 AM ET
Data refreshes hourly during market hours. Next update: 4:33 AM
Data refreshes hourly during market hours. Next update: 4:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NMTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
